... Collecting duct renalcellcarcinoma This subtype is very rare. The major feature is that the cancer cells can form irregular tubes. Unclassified renalcellcarcinoma Rarely, renalcell cancers are ... treatment and can also help your doctor determine if your cancer may be due to an inherited genetic syndrome. Clear cellrenalcellcarcinoma This is the most common form of renalcell carcinoma. ... 10 people with renal cellcarcinoma have this kind of cancer. When seen under a microscope, the cells that make up clear cell RCC look very pale or clear. Papillary renalcellcarcinoma This...
... GermanyKeywordschromophobe renalcellcarcinoma (chRCC);conventional renalcellcarcinoma (cRCC);glycosylphosphatidylinositol anchor; papillary renal cellcarcinoma (pRCC); renal oncocytomaCorrespondenceC. ... TNMstaging system of renalcell carcinoma. A Swiss experi-ence with 588 tumors. Cancer 89, 604–614.4 Hansel DE (2006) Genetic alterations and histopatho-logic findings in familial renal carcinoma. Histol ... papillary renalcell tumors. GenesChromosomes Cancer 3, 249–255.6 Brunelli M, Eble JN, Zhang S, Martignoni G,Delahunt B & Cheng L (2004) Eosinophilic and classicchromophobe renalcell carcinomas...
... RCC and normal tissue and secretion by the normal renal epithelium (humannormal kidney, HNK) and RCC cells. Normal and RCC tissues stainedpositive for TSP1, and the levels of TSP1 mRNA and ... patients with meta-static renal cancer: an update. Clin Cancer Res 10,6367S–6370S.6 Motzer RJ & Bukowski RM (2006) Targeted therapyfor metastatic renalcell carcinoma. J Clin Oncol 24,5601–5608.7 ... (2002) Theprognostic value of angiogenesis and metastasis-relatedgenes for progression of transitional cellcarcinoma ofthe renal pelvis. and ureter. Clin Cancer Res 8, 1863–1870.14 Slaton JW,...
... RA: Nephrectomy and inter-leukin-2 for metastatic renal- cell carcinoma. N Engl J Med2001, 345:1711-1712.21. Diner EK, Linehan M, Walther M: Response of papillary renal cell carcinoma in a solitary ... the Tumor-associ-ated Antigens RAGE-1, PRAME, and Glycoprotein 75 inHuman RenalCell Carcinoma: Candidates for T -Cell- basedImmunotherapies? Cancer Res 1998, 58:4090-4095.6. Griffiths RW, ... of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T -cell- basedimmunotherapy. Br J Cancer 2005, 93:670-677.Additional file 1MVA- and 5T4- specific antibody responses....
... diuretic use and coffee consumption asrisk factors for renalcell carcinoma. J Natl Cancer Inst 1986,77:351-356.20. Bruning T, Weirich G, Hornauer MA, Hofler H, Brauch H: Renal cell carcinomas ... sporadic and familial renal cell carcinomas have a common carcinogenic pathway and that at least one gene should be altered in both forms. Thishas been confirmed with the cloning of the VHL gene and the ... C, Negri E, D'Avanzo B, Franceschi S: Smoking and renalcell carcinoma. Cancer Res 1990, 50:5231-5233.18. Malker H, Malker B: Kidney cancer among leather workers.Lancet 1984, 1:56-57.19....
... duringthe differentiation of renal tubules representing the originof clear cellrenalcellcarcinoma (RCC) and in the regula-tion of the cell cycle of parietal epithelial cells of the Bow-man's ... frequentlysilenced gene in a cancer- specific manner, in particular inpancreatic, gastric, colon, ovarian, head neck squamous cell and hepatocellular carcinoma [14,30-35]. Thus, inorder to understand the underlying ... RCC cell lines were treated for 5 days with 1, 5 and 10 μM DAC(Sigma-Aldrich GmbH, Taufkirchen, Germany). Subse-quently untreated and DAC treated cells were harvested,lysed and total mRNA and/ or...
... Contre le Cancer (UICC) and the AmericanJoint Committee on Cancer (AJCC). Cancer 1997, 80:987-989.11. Freed SZ, Halperin JP, Gordon M: Idiopathic regression of metastasesfrom renalcell carcinoma. ... of the tumor-associated antigens RAGE-1,PRAME, and glycoprotein 75 in human renalcell carcinoma: candidatesfor T -cell- based immunotherapies?. Cancer Res 1998, 58:4090-4095.32. Scardino A, ... ofG250-targeted and T -cell- mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor. Cancer Res...
... methods [20], the renalcancercell line,phagocytic cells and endothelial cells were used todetect the toxicity of three modified PEI-derived materi-als in vitro.The OS-RC-2 cells were seeded ... healthy cells,but overexpression in many types of tumors, such as ovar-ian, colorectal andrenalcell carcinomas [26,31].Therefore , FA- PEAs:pVH L compl exes could bind to FRthat locates in cell ... the experiments and wrote the paper draft; LS conceived,instructed the experiments and revised the paper; SG and XX performedexperiments and analyzed data; ZX and ZP collected and validated tissuesamples;...
... 9:97http://www.translational-medicine.com/content/9/1/97Page 9 of 11 Cell lines and culture conditionsThe human colore ctal cancercell lines LoVo, SW480,HT29, HCT116 and LS174T were maintained in RPMI1640 (Gibco, Grand Island, NY, USA) supplementedwith ... inhibited cell proliferation and pro-moted cell senescence.After CK2a knockdown, the percentage of G0/G1phase cells significantly increased (t = -9.577, P <0.01), and the percent of S phase cells ... p53 and p21expression and decreased endogenous C-myc expression(Figure 4C). Thus, it can be inferred that the inhibitionof cell proliferation andcell cycle arrest in CK2a knock-down cells...
... methods [20], the renalcancercell line,phagocytic cells and endothelial cells were used todetect the toxicity of three modified PEI-derived materi-als in vitro.The OS-RC-2 cells were seeded ... toxicity,typically, several major cell types are used in vitro fortesting including phagocytic, epithelial, endothelial and various cancercell lines [20]. Therefore, besides the renal cancercell OS-RC-2, we ... healthy cells,but overexpression in many types of tumors, such as ovar-ian, colorectal andrenalcell carcinomas [26,31].Therefore , FA- PEAs:pVH L compl exes could bind to FRthat locates in cell...